Cargando…

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and nonalcoholic fatty liver disease (NAFLD). This work studied the increase in total FFA shown in NAFLD subjects to possibly characterize which fatty acids significantly accounted for the whole increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gambino, Roberto, Bugianesi, Elisabetta, Rosso, Chiara, Mezzabotta, Lavinia, Pinach, Silvia, Alemanno, Natalina, Saba, Francesca, Cassader, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848935/ https://www.ncbi.nlm.nih.gov/pubmed/27043543 http://dx.doi.org/10.3390/ijms17040479

Ejemplares similares

Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
por: Musso, Giovanni, et al.
Publicado: (2013)

Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers
por: Sanna, Claudia, et al.
Publicado: (2016)

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
por: Armandi, Angelo, et al.
Publicado: (2021)

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
por: Musso, Giovanni, et al.
Publicado: (2020)

Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs
por: Petroni, Maria Letizia, et al.
Publicado: (2023)

Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2023)

Obesity, Diabetes, and Gut Microbiota: The hygiene hypothesis expanded?
por: Musso, Giovanni, et al.
Publicado: (2010)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
por: Gaggini, Melania, et al.
Publicado: (2013)

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
por: Musso, Giovanni, et al.
Publicado: (2019)

Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2022)

HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Di Costanzo, Alessia, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
por: Longato, Lisa
Publicado: (2013)

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
por: Liu, Qing, et al.
Publicado: (2010)

Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts
por: Foglia, Beatrice, et al.
Publicado: (2019)

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
por: Kazankov, Konstantin, et al.
Publicado: (2020)

Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Castelnuovo, Gabriele, et al.
Publicado: (2023)

Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates
por: Salvoza, Noel, et al.
Publicado: (2022)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease
por: Mirza, M. S.
Publicado: (2011)

The Ratio of Unsaturated to Saturated Fatty Acids is a Distinguishing Feature of NAFLD in Subjects With Metabolic Disease
por: Falcone, John N, et al.
Publicado: (2021)

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2016)

Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Hyperglycemia in an Adult Italian Population-Based Cohort
por: Gambino, Roberto, et al.
Publicado: (2010)

The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
por: Armandi, Angelo, et al.
Publicado: (2021)

Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) – an 11-Year Prospective Study
por: Lallukka, Susanna, et al.
Publicado: (2017)

Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
por: Jang, Yun Seo, et al.
Publicado: (2023)

Factors contributing to nonalcoholic fatty liver disease (NAFLD) and fat deposition after pancreaticoduodenectomy: A retrospective analysis
por: Izumi, Hideki, et al.
Publicado: (2023)

Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD)
por: Notarnicola, Maria, et al.
Publicado: (2017)

Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation
por: Bo, Simona, et al.
Publicado: (2018)

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Prevalence of NAFLD in Healthy and Young Male Individuals
por: Niaz, Asif, et al.
Publicado: (2011)

Consuming More of Daily Caloric Intake at Dinner Predisposes to Obesity. A 6-Year Population-Based Prospective Cohort Study
por: Bo, Simona, et al.
Publicado: (2014)

Predictive role of the Mediterranean diet on mortality in individuals at low cardiovascular risk: a 12-year follow-up population-based cohort study
por: Bo, Simona, et al.
Publicado: (2016)

Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2014)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial
por: Bo, Simona, et al.
Publicado: (2018)

Capsaicin suppresses liver fat accumulation in high-fat diet-induced NAFLD mice
por: Shin, Mi Kyung, et al.
Publicado: (2020)

Dietary flavonoid intake and cardiovascular risk: a population-based cohort study
por: Ponzo, Valentina, et al.
Publicado: (2015)

NAFLD or comorbidities, that is the question
por: Ponziani, Francesca Romana, et al.
Publicado: (2020)

The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD
por: Ma, Minjuan, et al.
Publicado: (2019)

Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease
por: Gaggini, Melania, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sjdg5m0uc9v42837vsi8lpvdl9